Cancer research is steadily moving toward precision, designing therapies that target tumours more selectively while limiting damage to healthy tissue. One of...

Drug discovery has always been constrained by time. From early target validation through lead optimization, every delay increases cost and risk. In...

Pharmaceutical research is changing. As many traditional small-molecule programs reach their limits, peptide-based drugs are playing a larger role in discovery pipelines....